Slovenian researchers help prove benefits of DNA-adapted health treatments

Ljubljana, 3 February - A number of Slovenian doctors and researchers took part in a breakthrough international study showing that the use of medicines tailored to patients' pharmacogenetic data lowers adverse drug effects by 30%. This is the first study to prove the benefits of prescribing medicines based on patient's genetic markers.